Creative Biolabs is a leading service provider of scFv repertoire analysis. We have developed an advanced Magic™ scFv repertoire analysis platform for the identification of antibody with high affinity and specificity. Combined with our phage display technology, we could generate antibodies from diverse species, such as human, rabbit, chicken, dog, and monkey. More than hundreds of possible binders could be identified by Magic™ analysis in a short period, which greatly improves the efficiency of library selection.

Background

Single-chain variable fragment (scFv) is a type of antibody fragment that has the smaller unit of immunoglobulin molecule with antigen binding abilities. It consists of variable regions of heavy (VH) and light (VL) chains linked by a flexible peptide linker of 10 to 25 amino acids. It is able to be functionally expressed in E. coli, therefore allows the antibody engineering, such as improving the affinity and altering the binding specificity.

Figure 1. scFv antibody.¹

Magic™ ScFv Repertoire Analysis Service

Magic™ scFv repertoire analysis is an advanced scFv sequence analysis method developed by Creative Biolabs based on the Magic™ Therapeutic Antibody Discovery Platform (MTADP). Compared to the conventional hybridoma method, MTADP can identify a much larger number of antibody candidates. The more antibodies you get from the library, the more possible and functional antibodies could be expected. It's critical to characterize the scFv repertoires for discovery, selection, and optimization of the therapeutic and diagnostic antibodies. For example, the in vitro display and selection will result in large numbers of antibody candidates. The conventional method is using Sanger sequencing to analyze the selected clones. However, there are many drawbacks of this method, such as low throughput, high rate of false positives, and extra rounds of selection. Magic™ scFv Repertoire Analysis applies the most advanced methodology that allows sequencing of paired heavy and light variable regions. It overcomes the existing limitations of the traditional sequencing method, provides the result with high-throughput and high quality. Through this analysis, the binder could be selected in an efficient and cost-effective manner.

Magic™ scFv repertoire analysis is the most advantageous technology to identify scFv from an antibody library with a larger of variants. Through this powerful platform, the massive antibody could be determined. Creative Biolabs provides one-stop antibody discovery, screening, and analysis service. With this strategy, we have discovered a list of custom scFv antibodies for our customers. We offer tailored service to meet our customers' unique requirements.

Other optional antibody repertoire analysis services:

• Magic™ Fab Repertoire Analysis
• Magic™ VHH Repertoire Analysis

FAQ

1. What is scFv repertoire sequencing analysis?

   scFv repertoire sequencing analysis is a technique used to analyze the diversity of single-chain variable fragments (scFv) within an immune repertoire. scFv consists of the variable regions of the heavy (VH) and light (VL) chains of antibodies, connected by a short linker peptide. This method allows researchers to explore the range and frequency of scFv sequences, providing insights into the immune response, antibody discovery, and therapeutic development.

2. How does scFv repertoire sequencing differ from traditional antibody sequencing?

   Unlike traditional antibody sequencing, which typically focuses on full-length antibodies or individual variable regions, scFv repertoire sequencing analyzes the combined variable regions (VH and VL) as a single functional unit. This method preserves the natural pairing of the variable regions, allowing for a more accurate representation of antigen-binding specificities and enhancing the potential for discovering novel therapeutic antibodies.

3. What are the primary applications of scFv repertoire sequencing analysis?

   scFv repertoire sequencing analysis is used in therapeutic antibody discovery, vaccine development, and studying immune responses in health and disease. It is particularly valuable in identifying scFv fragments with high affinity and specificity for therapeutic targets. Additionally, this technique can be applied to monitor immune responses during infections or vaccinations and to explore the diversity of antibody responses in autoimmune diseases or cancer.

4. How does scFv repertoire sequencing contribute to therapeutic antibody development?

   scFv repertoire sequencing enables the identification of novel antibody fragments with high specificity and affinity for therapeutic targets. By analyzing the natural immune response, researchers can discover scFv sequences that may serve as the basis for developing monoclonal antibodies, bispecific antibodies, or antibody-drug conjugates. This approach accelerates the discovery process and provides a diverse pool of candidates for therapeutic development.

5. How is scFv repertoire sequencing analysis used in cancer research?

   In cancer research, scFv repertoire sequencing analysis is used to study the diversity of immune responses against tumor antigens. By analyzing the scFv sequences from tumor-infiltrating lymphocytes or patient blood samples, researchers can identify antibody fragments that target specific cancer cells. This information can guide the development of cancer immunotherapies, including monoclonal antibodies and CAR-T cells, and provide insights into the effectiveness of immune responses during treatment.

6. What is the significance of VH and VL pairing in scFv repertoire sequencing analysis?

   The VH and VL pairing in scFv repertoire sequencing is crucial because it determines the antigen-binding specificity of the antibody fragment. Accurate pairing ensures that the scFv retains its natural binding properties, allowing researchers to identify functional antibody fragments that can be developed into therapeutic agents. Mispaired sequences may lead to inaccurate conclusions about antigen specificity and reduce the effectiveness of downstream applications.

7. What role does bioinformatics play in scFv repertoire sequencing analysis?

   Bioinformatics is essential in scFv repertoire sequencing analysis for processing and interpreting the large volumes of data generated. Advanced algorithms are used to assemble scFv sequences, identify clonotypes, and analyze the diversity and frequency of specific sequences. Bioinformatics tools also help in visualizing the repertoire, comparing it across different samples, and identifying patterns that are relevant for antibody discovery, immune monitoring, and therapeutic development.

Resources

Use the resources in our library to help you understand your options and make critical decisions for your study.

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.